Results 11 to 20 of about 2,445 (218)

Smart drugs and neuroenhancement: what do we know?

open access: yesFrontiers in Bioscience-Landmark, 2021
Introduction: Smart drugs are among the most common drugs used by students. It is estimated that they are second in incidence after cannabis. Although they are usually used for diseases such as attention deficit hyperactivity disorder (ADHD) and dementia,
Massimiliano Esposito   +7 more
doaj   +1 more source

Value-Added Products from Ethanol Fermentation—A Review

open access: yesFermentation, 2021
Global demand for renewable and sustainable energy is increasing, and one of the most common biofuels is ethanol. Most ethanol is produced by Saccharomyces cerevisiae (yeast) fermentation of either crops rich in sucrose (e.g., sugar cane and sugar beet ...
Timothy J. Tse   +4 more
doaj   +1 more source

A real‐world survey of the diagnostic journey, current treatment, and burden of mild cognitive impairment or dementia due to Alzheimer's disease in China [PDF]

open access: yesAlzheimers Dement
Abstract Background We aimed to describe the diagnostic journey, current treatment, caregiving needs, and burden of patients with mild cognitive impairment (MCI) and Alzheimer's disease (AD) dementia in China. Method Data were drawn from the Adelphi Real World AD Disease Specific Programme™, a cross‐sectional survey of neurologists and their patients ...
Xin J   +7 more
europepmc   +2 more sources

Nootropics use in the workplace. Psychiatric and ethical aftermath towards the new frontier of bioengineering [PDF]

open access: yes, 2020
OBJECTIVE: The authors have sought to expound upon and shed a light on the rise of nootropics, which have gradually taken on a more and more relevant role in workplaces and academic settings.
Bersani, G   +5 more
core   +1 more source

Smart drugs are as a dangerous model of psychoactive substance use [PDF]

open access: yesСовременная зарубежная психология, 2021
When examining the factors of the use of psychoactive substances (PAS) by young people, recreational consumption has traditionally been studied. The second well-known causal model to examine psychoactive substances was its interpretation as a way of ...
Rychkova O.V.
doaj   +1 more source

The value of information service for the rational use of nootropics in preferential drug provision

open access: yesКачественная клиническая практика, 2020
The rational prescription of medicines with preferential drugs provision, including nootropics, which are widely used in patients receiving pharmacotherapy under the «Program for Providing Certain Categories of Citizens with Necessary Drugs», is possible
E. V. Eliseeva   +3 more
doaj   +1 more source

Potential Herb–Drug Interactions in the Management of Age-Related Cognitive Dysfunction

open access: yesPharmaceutics, 2021
Late-life mild cognitive impairment and dementia represent a significant burden on healthcare systems and a unique challenge to medicine due to the currently limited treatment options.
Maria D. Auxtero   +4 more
doaj   +1 more source

Cognitive Enhancement: Treating or Cheating? [PDF]

open access: yes, 2015
In this article I provide an overview of the moral and medical questions surrounding the use of cognitive enhancers. This discussion will be framed in light of 4 key considerations: (1) is there a difference between therapy and enhancement?
Whetstine, Leslie M.
core   +1 more source

Smart drugs et nootropiques

open access: yesSocio-anthropologie, 2021
This article aims at questioning the promise of cognitive optimization based on the promotion of substances classified as “nootropics”. This paper focuses on the circulation of this promise and the products that support it, as well as on contemporary ...
Félix Denis
doaj   +1 more source

Cerebroprotective prevention of memory disorders using sodium valproate

open access: yesZaporožskij Medicinskij Žurnal, 2013
Epilepsy is the disease resulting in impaired cognitive function. The paper deals with the use of nootropics against the background of an anticonvulsant effect.
A. V. Ivanov
doaj   +1 more source

Home - About - Disclaimer - Privacy